Recombinant Hepatitis B Vaccine Market Key Drivers and Forecast 2025-2032
Recombinant Hepatitis B Vaccine Market Drivers And Trends The recombinant hepatitis B vaccine market size was valued at USD 2.5 billion in 2022 and is projected to reach USD 4.3 billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030. This growth is driven by increasing awareness about hepatitis B, especially in […]
Continue Reading